High-risk UPPRS myeloma cells interact actively with immune cells via the LAMININ pathway, and this may be associated with increased cell-adhesion of myeloma cells and, thus, the acquisition of drug resistance [36]. Here, LAMB2 is linked to plasma cell myeloma.